ANCA-associated vasculitides—advances in pathogenesis and treatment
Top Cited Papers
- 5 October 2010
- journal article
- review article
- Published by Springer Nature in Nature Reviews Rheumatology
- Vol. 6 (11) , 653-664
- https://doi.org/10.1038/nrrheum.2010.158
Abstract
Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAV) include Wegener granulomatosis, microscopic polyangiitis, Churg-Strauss syndrome and renal-limited vasculitis. This Review highlights the progress that has been made in our understanding of AAV pathogenesis and discusses new developments in the treatment of these diseases. Evidence from clinical studies, and both in vitro and in vivo experiments, supports a pathogenic role for ANCAs in the development of AAV; evidence is stronger for myeloperoxidase-ANCAs than for proteinase-3-ANCAs. Neutrophils, complement and effector T cells are also involved in AAV pathogenesis. With respect to treatment of AAV, glucocorticoids, cyclophosphamide and other conventional therapies are commonly used to induce remission in generalized disease. Pulse intravenous cyclophosphamide is equivalent in efficacy to oral cyclophosphamide but seems to be associated with less adverse effects. Nevertheless, alternatives to cyclophosphamide therapy have been investigated, such as the use of methotrexate as a less-toxic alternative to cyclophosphamide to induce remission in non-organ-threatening or non-life-threatening AAV. Furthermore, rituximab is equally as effective as cyclophosphamide for induction of remission in AAV and might become the standard of therapy in the near future. Controlled trials in which specific immune effector cells and molecules are being therapeutically targeted have been initiated or are currently being planned.Keywords
This publication has 117 references indexed in Scilit:
- Rituximab versus Cyclophosphamide for ANCA-Associated VasculitisNew England Journal of Medicine, 2010
- A CD8+ T cell transcription signature predicts prognosis in autoimmune diseaseNature Medicine, 2010
- Patients with Wegener’s granulomatosis demonstrate a relative deficiency and functional impairment of T‐regulatory cellsImmunology, 2010
- Confirmation of the genetic association of CTLA4 and PTPN22 with ANCA-associated vasculitisBMC Medical Genetics, 2009
- Netting neutrophils in autoimmune small-vessel vasculitisNature Medicine, 2009
- Molecular mimicry in pauci-immune focal necrotizing glomerulonephritisNature Medicine, 2008
- CpG oligodeoxynucleotide stimulates production of anti-neutrophil cytoplasmic antibodies in ANCA associated vasculitisBMC Immunology, 2008
- Rats and mice immunised with chimeric human/mouse proteinase 3 produce autoantibodies to mouse Pr3 and rat granulocytesAnnals of the Rheumatic Diseases, 2007
- Standardised assessment of membrane proteinase 3 expression. Analysis in ANCA-associated vasculitis and controlsAnnals of the Rheumatic Diseases, 2007
- Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studiesAnnals of the Rheumatic Diseases, 2007